Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. At Inhibrx, our mission is to deliver optimized, biologic therapeutics to people with life-threatening conditions.

This National Cancer Survivors Month, we honor those navigating cancer survivorship and the strength carried through eve...
06/11/2026

This National Cancer Survivors Month, we honor those navigating cancer survivorship and the strength carried through every stage of that journey.

Their experiences reinforce the importance of continued research and scientific progress across oncology.

Learn more about our oncology research: https://tinyurl.com/catfc3pt

Our team is onsite at the 2026 ASCO Annual Meeting and looking forward to engaging with the oncology community.Stop by o...
05/31/2026

Our team is onsite at the 2026 ASCO Annual Meeting and looking forward to engaging with the oncology community.

Stop by our booth (Booth #37116) to learn more about our ongoing research programs and commitment to advancing potential new treatment options for patients.

Inhibrx is heading to the 2026 ASCO Annual Meeting, where updated data in chondrosarcoma and colorectal cancer from the ...
05/22/2026

Inhibrx is heading to the 2026 ASCO Annual Meeting, where updated data in chondrosarcoma and colorectal cancer from the ozekibart (INBRX-109) program will be presented.

Visit our medical booth ( #37116) to connect with our team and learn more about our ongoing research.

National Cancer Research Month is a reminder that progress in oncology depends on continued scientific discovery.Researc...
05/05/2026

National Cancer Research Month is a reminder that progress in oncology depends on continued scientific discovery.

Research plays an essential role in improving our understanding of cancer and advancing new approaches for patients and communities affected by these diseases.

Learn more about our oncology research: https://tinyurl.com/jrkxavnx

We remain committed to pursuing science that may help address significant unmet needs and contribute to the future of tr...
05/01/2026

We remain committed to pursuing science that may help address significant unmet needs and contribute to the future of treatment innovation.

Progress in childhood cancers depends on continued research, collaboration, and determinationβ€”and we are proud to be part of that effort with our ozekibart program in Ewing sarcoma.

Learn more about our ongoing research in Ewing sarcoma with our ozekibart (INBRX-109) program: https://tinyurl.com/6w46a4hm

Inhibrx was pleased to partner with the Linda Vista Innovation Center by welcoming military-connected students from the ...
04/29/2026

Inhibrx was pleased to partner with the Linda Vista Innovation Center by welcoming military-connected students from the Chula Vista Elementary School District to our office for a field trip as part of their biotech camp.

The visit gave students a chance to experience a professional science working environment as part of a design-thinking challenge connected to their labs.

We are grateful to support programs that foster learning, spark creativity, and introduce students to future STEM opportunities.

β€œπ˜›π˜©π˜¦ 𝘴𝘡𝘳𝘦𝘯𝘨𝘡𝘩 𝘰𝘧 𝘰𝘢𝘳 π˜ͺ𝘯𝘯𝘰𝘷𝘒𝘡π˜ͺ𝘰𝘯 π˜ͺ𝘴 𝘳𝘰𝘰𝘡𝘦π˜₯ π˜ͺ𝘯 𝘡𝘩𝘦 𝘴𝘡𝘳𝘦𝘯𝘨𝘡𝘩 𝘰𝘧 𝘰𝘢𝘳 𝘀𝘢𝘭𝘡𝘢𝘳𝘦!”This week, we celebrated Earth Day with a few ...
04/24/2026

β€œπ˜›π˜©π˜¦ 𝘴𝘡𝘳𝘦𝘯𝘨𝘡𝘩 𝘰𝘧 𝘰𝘢𝘳 π˜ͺ𝘯𝘯𝘰𝘷𝘒𝘡π˜ͺ𝘰𝘯 π˜ͺ𝘴 𝘳𝘰𝘰𝘡𝘦π˜₯ π˜ͺ𝘯 𝘡𝘩𝘦 𝘴𝘡𝘳𝘦𝘯𝘨𝘡𝘩 𝘰𝘧 𝘰𝘢𝘳 𝘀𝘢𝘭𝘡𝘢𝘳𝘦!”

This week, we celebrated Earth Day with a few green initiatives. Taking the time for intentional connection, space to create, and recharge as a team.

We hosted our first Great Book Exchange while sharing stories and giving pre-loved books a new home.

Staff enjoyed getting their artistic juices flowing through painting flowerpots and planting new life to brighten our workspace.

Inhibrx is excited to share a clinical update on ozekibart (INBRX-109) in late line colorectal cancer.Read the full pres...
04/21/2026

Inhibrx is excited to share a clinical update on ozekibart (INBRX-109) in late line colorectal cancer.

Read the full press release on our website: https://tinyurl.com/yc7e6b6a

We’re proud to announce that two abstracts from our ozekibart (INBRX-109) program have been accepted for presentation at...
04/21/2026

We’re proud to announce that two abstracts from our ozekibart (INBRX-109) program have been accepted for presentation at the upcoming 2026 ASCO Annual Meeting.

➑️ Oral presentation: Secondary efficacy endpoints from the Phase 2 ChonDRAgon study in conventional chondrosarcoma
➑️ Poster presentation: Phase 1 study of ozekibart (INBRX-109) combined with chemotherapy in locally advanced or metastatic, unresectable colorectal adenocarcinoma

These presentations reflect our continued commitment to improving patient outcomes.

Learn more here: https://tinyurl.com/2wt55td7

Address

Torrey Pines Science Park 11025 N Torrey Pines Road #200
La Jolla, CA
92037

Website

Alerts

Be the first to know and let us send you an email when Inhibrx Biosciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category